156 related articles for article (PubMed ID: 16188904)
41. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
42. [Sleep apnea-hypopnea syndrome at the onset of acromegaly due to ectopic secretion by a pancreatic neuroendocrine tumor].
Senent C; Chiner E; Sancho-Chust JN
Arch Bronconeumol; 2009 Apr; 45(4):205-6. PubMed ID: 19324489
[No Abstract] [Full Text] [Related]
43. Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma.
Suwaki N; Masuyama H; Mizutani Y; Kodama J; Hiramatsu Y
J Obstet Gynaecol Res; 2006 Feb; 32(1):94-8. PubMed ID: 16445533
[TBL] [Abstract][Full Text] [Related]
44. Tumor hypercalcemia.
Roof BS
Calif Med; 1973 Jan; 118(1):35-6. PubMed ID: 4346690
[No Abstract] [Full Text] [Related]
45. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
46. [Hypercalcemia in patients with malignant tumor (author's transl)].
Abe K
Rinsho Byori; 1975 May; 23(5):371-4. PubMed ID: 1172565
[No Abstract] [Full Text] [Related]
47. Hypercalcaemia secondary to secretion of parathyroid hormone related protein from a somatostatinoma of the pancreas.
Williams EJ; Ratcliffe WA; Stavri GT; Stamatakis JD
Ann Clin Biochem; 1992 May; 29 ( Pt 3)():354-7. PubMed ID: 1610113
[No Abstract] [Full Text] [Related]
48. [Hypercalcemia].
Ziegler R
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):988. PubMed ID: 9280719
[No Abstract] [Full Text] [Related]
49. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia.
Ferrel B; Franko J; Tee MC
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858893
[TBL] [Abstract][Full Text] [Related]
50. [Humoral mechanisms in neoplastic hypercalcemia].
Gennari C; Montagnani M; Nami R; Francini G
Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
[No Abstract] [Full Text] [Related]
51. Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas.
Pavel ME; Hoppe S; Papadopoulos T; Linder V; Mohr B; Hahn EG; Lohmann T; Schuppan D
Horm Metab Res; 2006 Feb; 38(2):112-8. PubMed ID: 16523412
[TBL] [Abstract][Full Text] [Related]
52. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic Neuroendocrine Tumor With Humoral Hypercalcemia and High Tumor PD-L1 Score.
Copur MS; Vargas L; Wedel W; Merani S; Cushman-Vokoun A; Drincic A
Oncology (Williston Park); 2020 Dec; 34(12):548-552. PubMed ID: 33395496
[TBL] [Abstract][Full Text] [Related]
54. Clinical inquiries. How should you evaluate elevated calcium in an asymptomatic patient?
Sharma B; Misicko NE; Hitchcock K; Neher JO
J Fam Pract; 2008 Apr; 57(4):267-9. PubMed ID: 18394361
[No Abstract] [Full Text] [Related]
55. Measurements of chromogranin B can serve as a complement to chromogranin A.
Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
[TBL] [Abstract][Full Text] [Related]
56. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
[TBL] [Abstract][Full Text] [Related]
57. Pancreatic neuroendocrine tumour (PNET) occurring with Guillian-Barré syndrome (Re: ANZ J. Surg. 2010; 80: 297).
Yu TC
ANZ J Surg; 2010 Dec; 80(12):951. PubMed ID: 21114745
[No Abstract] [Full Text] [Related]
58. Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia.
Buckle RM; McMillan M; Mallinson C
Br Med J; 1970 Dec; 4(5737):724-6. PubMed ID: 5491259
[No Abstract] [Full Text] [Related]
59. [Hypercalcemia].
Walther J
MMW Fortschr Med; 2010 Sep; 152(36):33-4. PubMed ID: 21192464
[No Abstract] [Full Text] [Related]
60. A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours.
Stronge RL; Turner GB; Johnston BT; McCance DR; McGinty A; Patterson CC; Ardill JE
Ann Clin Biochem; 2008 Nov; 45(Pt 6):560-6. PubMed ID: 18782815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
